Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer

As a clinically heterogeneous subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with a poor clinical outcome and a high relapse rate. Conventional chemotherapy and radiotherapy are effective treatments for patients with TNBC. However, the prognosis of TNBC remains unsatisf...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Wu, Nan, Zhang, Jinghua, Zhao, Jing, Mu, Kun, Zhang, Jun, Jin, Zhao, Yu, Jinpu, Liu, Juntian
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2018
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144355/
https://ncbi.nlm.nih.gov/pubmed/30250564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9290
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares